Reason for request
Inscription
Mise à disposition d'un médicament similaire à TRAVATAN 40 µg/ml, collyre en solution mais formulé sans conservateur.
Clinical Benefit
| Substantial |
Le service médical rendu par VIZITRAV 40 µg/ml, collyre en solution est important dans les indications de l’AMM. |
Clinical Added Value
| no clinical added value |
VIZITRAV 40 µg/ml, collyre en solution n’apporte pas d’amélioration du service médical rendu (ASMR V) par rapport à TRAVATAN 40 µg/ml, collyre en solution. |
eNq1mF1v2jAUhu/5FVEudkcS6AdhS6g21m5Ircpo0abdIJMcilmwU38E2l8/h9CVTo7aGnyDRBzec3LO8eOXRGfrZeYUwDimJHZbXuA6QBKaYnIXu+Pbi2bonvUa0QIVaOe2jhd4rbbrJBniPHbLVW8KiHDv19XlV1C/B+b2Gk5EpwtIxIv7pMCZ9x3x+RXKy3ucqKA4dZYg5jSN3VyKzVUn4oKpLHoryv7wHCUQ+dsru6uLyfHu9cgvxd6gKjmwS0TutKJAjDQTyRgQ0UcC7ih70ErPkkk77JwGQWgUAvMRcCpZAkMk5kNGC5xCqo+EMg5GQWar9AZYkYEog2jF/UWy5EbiaIHWI7gf6JP+rFb7Yi2aQbPV6XQ7YbsddIOgbRSK7ZRKPzzqIfyyId2j4/DUB+IX+BELhopm+UFzRrkw7NOQMoEySx3CvP9y1izFYXD/6iSkmOcZevAWPDctFWJILQNTRLD3IOUT3DLFqEzV7D99IrPMf2fW4y1BLGVcAqpPJRE1ILkYmRaiT4mAdX1Hzdgn1ttZxMAPJ/tIiZ77QznNcGKKNwUgCVyMR4N6utkCwxfEYczskeEnJild8cMTZ7fDlrLPN9DUiuYsbU3a3fC0dXJivKF+q3GqOXnOJaM5+IpFmO+DmAGZ0X3hoiZUL/U0n1ZGc2OJaIIyqDFFTUPmqJl88nDWpt7ejqoWtKLfzm9NR+WHBPZws/mqlcZp/K/JZkC2QXk1mK8lXm3hOJ8cBSdl+h/QMv/05LZjQ2ddib7BWB+HR2ZeUTI9duZC5Pyj769WK2+OeJMjVVZvxt52RJxpq3GIiigePzfY3v8AK16h8k4Viy2lPq0O2fe11HQvv+Ym9nXI299vnbg2hmAS9uhFhX1rcB6cH573z/bYWtrDF9SxF2ZjZZHAlNiyVXKqVdzvhFF9JRdMAeJ6NsM1r2dq5zLyq1dDvUbkl6+Feo2/fZUYZQ==
FYDTL2vmxETwpkzg
